-
I-Dabrafenib
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Dabrafenib -
I-Aprocitetan
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Aprocitetan -
I-Etrasimod
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Etrasimod I-Ulceratuve Colitis(UC) I-Arena(Pfizer) Mar.05,2030 -
I-Tirzepatide
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Tirzepatide Thayipha isifo sikashukela sohlobo 2, ukunciphisa umzimba Eli Lilly Jan.05,2036 -
I-Semaglutide
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Semaglutide Isifo sikashukela sohlobo 2, ukunciphisa umzimba I-Novo Nordisk Dec.05,2031 -
I-Oteseconazole
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Oteseconazole Yehlisa izinga lezehlakalo ze i-candidiasis ye-vulvovaginal evamile
I-MycoviaPharmaceuticals Apr.22,2031 -
I-Finerenone
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Finerenone Isifo sikashukela i-Nephropathy I-Bayer Ephreli.12,2029 -
I-Vibegron
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Vibegron OAB I-Urovant Dec.01,2030 -
I-Caivasertib
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Caivasertib umdlavuza webele AstraZeneca Mar.10.2030 -
I-Resmetirom
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Resmetirom NASH Roche Sep.12,2026 -
I-Darolutamide
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Darolutamide ukwelashwa komdlavuza we-prostatic I-Bayer Mashi. 25,2033 -
Upadacitinib
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) Upadacitinib I-Atopic Dermatitis Inkampani ABBVIE INC Dec.01,2030